In COVID-19 clinical update #52, Daniel Griffin reviews differences in attack rates between children and adults, J&J vaccine phase III data, G6PD deficiency and vaccines, NIH halts convalescent plasma trial, dexamethasone in hospitalized patients, data on tocilizumab, and long COVID in children.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

SARS-CoV-2 attack rates in children and adults (Clin Inf Dis)
Documents for J&J COVID-19 vaccine review (FDA)
Convalescent plasma and clinical outcomes (JAMA)
NIH halts convalescent plasma trial (NIH)
Dexamethasone in hospitalized COVID-19 patients (NEJM)
Tocilizumab in hospitalized COVID-19 patients (NEJM)
Update on long COVID prevalence (UK ONS)
Letters read on TWiV 727
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 727: COVID-19 clinical update #52 with Dr. Daniel Griffin